Henry J. Fuchs, President, Worldwide R&D at BIOMARIN PHARMACEUTICAL INC (BMRN), sold 17,700 shares at $87.86 ($1.6M) on 2019-03-25, disclosed to the SEC on 2019-03-26.
Seasonal sale ($1.6M) by President, Worldwide R&D — this insider has traded BMRN in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $88.05 | 5,836 | $514K | 33.0% |
| 2 | $87.86 | 5,932 | $521K | 33.5% |
| 3 | $87.86 | 5,932 | $521K | 33.5% |
| Total | $87.92 avg | 17,700 | $1.6M | 100% |
| Filing → |
| MRTX | SELL | 2022-02-14 | $1.4M | — | Filing → |
| MRTX | SELL | 2020-12-16 | $4.7M | — | Filing → |
| MRTX | SELL | 2020-08-11 | $1.6M | — | Filing → |